Refine
Language
- English (2) (remove)
Keywords
- CAP (1)
- Entscheidungsprozesse (1)
- Kaltes Plasma (1)
- Medizinoekonomie (1)
- Plasmamedizin (1)
- Pricing (1)
- Wirtschaftlichkeit (1)
Institute
- Klinik und Poliklinik fĂĽr Mund-, Kiefer- und Gesichtschirurgie/Plastische Operationen (2) (remove)
Due to a variety of plasma sources in terms of type of discharge, energy yield, working gas or geometric factors, it is recommended to standardize the study protocol by choosing a plasma source and easy access to rugged tumor surfaces as demonstrated by the CAP-plasma-jet. The intention of the trial shall be to optimize the plasma jet for tumor site capability and operating room implementation.
It makes sense to start clinical trials in plasma medicine with the treatment of head and neck squamous cell carcinoma patients of infected wounds and ulcerations.
CAP is able to reduce contamination of cancer ulcerations and the typical fetid odor that often accompanies head and neck cancer patients. The intention of the trial shall be to evaluate the efficiency of decontamination in head and neck cancer ulcerations in terms of pathogenic species, amount of reduction and reliability.
Standardize study protocol:
Phase I, clinical explorative single-arm, randomized, open, multicenter
Primary objective
Reduction of microbial burden of cancer ulcerations by application of CAP
Secondary objective:
Reduction of tumor following local CAP application
Inclusion:
20 Patients suffering from locally advanced oral cavity carcinoma with open tumor surfaces, treated with palliative intention and no more curative treatment options
Exclusion:
No wish for treatment, no compliance and understanding the protocol of the clinical study
Efficacy:
reduction of microbial burden; Documentation of visible changes by photography; Pathohistological and biochemical examination of specimen, taken from the tumor area and control areas
Procedure:
Plasma is applied for 1 minute per cm², spot area of 3 mm diameter distance between nozzle and tumor surface of 14 mm. 3 times/week with a break of 1 week followed by a repeated cycle for another week.
Conclusion:
The most important intention of the trial from the clinician’s point of view shall be to make CAP-treatment an effective and well-accepted addition to standard cancer therapy based upon EBM at least in palliative medicine.
The present work examines the decision-making process of clinicians and managers in terms of pricing. This dissertation attempts to make often unconscious processes in both the clinical and economic areas more transparent. Due to this increase in transparency and an illustration of the overall decision-making process, a prioritization of the decision-drivers is enabled. Similarily, overall decision-making on stakeholder level is improved. The findings of this work are based on a dual sample: The paper primarily combines qualitative expert discussions in the clinical field with a quantitative manager survey. Therefore, the advancement of knowledge is specifically furthered in terms of pricing decision-making, as well as specific economic and thematic aspects. These form the basis for clinical/managerial decision-making. Since such specific understanding enables better acting and reacting during the negotiation processs, clients of medical device companies (eg clinics) could additionally benefit from improved understanding. Although the focus of this work rests on the clinical area, this paper also examines how companies of the medical technology industry could offer more economic medical products by means of using the instrument of pricing. Based on an interdisciplinary approach and a collection of primary data, this work also discusses a solution approach for corporate/entrepreneurial inefficiencies discovered in this paper. A final conceptual model illustrates different value allocations from both stakeholder groups (clinicians vs. managers). With regard to the research focus, the conceptual model is understood as a holistic solution for recognizing and correcting business gaps in the areas of knowledge transfer, innovation, knowledge of markets and standardization of processes.
